In a mouse model of diet-induced obesity, treatment with the Cannabinoid receptor 1 (CB1) antagonist AM251 resulted in weight loss and reduced inflammation 80. Here, CNR1 is linked to obesity due to melanocortin 4 receptor deficiency.